Safety and efficacy findings in the first-in-human trial (FIH) of the oral splice modulator branaplam in type 1 spinal muscular atrophy (SMA): interim results
Authors:
- L. CharnasLCL. Charnas
- E. VoltzEVE. Voltz
- C. PfisterCPC. Pfister
- T. PetersTPT. Peters
- A. HartmannAHA. Hartmann
- C. Berghs-ClairmontCBC. Berghs-Clairmont
- J. PraestgaardJPJ. Praestgaard
- M. de RaspideMRM. de Raspide
- N. DeconinckNDN. Deconinck
- A. BornABA. Born
- G. BaranelloGBG. Baranello
- E. BertiniEBE. Bertini
- 1 October 2017
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 27, S207-S208